PYC Therapeutics Ltd
ASX:PYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
I
|
Instil Bio Inc
NASDAQ:TIL
|
US |
|
Cahayasakti Investindo Sukses Tbk PT
IDX:CSIS
|
ID |
|
I
|
Ibersol SGPS SA
ELI:IBS
|
PT |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
Diversified Royalty Corp
TSX:DIV
|
CA |
|
S
|
Streit Mecanique SA
PAR:MLSTR
|
FR |
|
Bank Mestika Dharma Tbk PT
IDX:BBMD
|
ID |
|
Altron Ltd
F:RY7A
|
ZA |
Wall Street
Price Targets
PYC Price Targets Summary
PYC Therapeutics Ltd
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.63 AUD
with a low forecast of 2.27 AUD and a high forecast of 5.21 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PYC's stock price target?
Price Target
3.63
AUD
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.63 AUD
with a low forecast of 2.27 AUD and a high forecast of 5.21 AUD.
What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
66%
For the last 13 years the
compound annual growth rate for
PYC Therapeutics Ltd's revenue is
22%.
The projected
CAGR
for the next 3 years is
66%.
